COR

Prezzo Cencora Inc.

Closed
COR
$320,89
-$0,07(-0,02%)

*Data last updated: 2026-04-08 00:42 (UTC+8)

As of 2026-04-08 00:42, Cencora Inc. (COR) is priced at $320,89, with a total market cap of $62,42B, a P/E ratio of 38,97, and a dividend yield of 0,71%. Today, the stock price fluctuated between $318,28 and $322,94. The current price is 0,82% above the day's low and 0,63% below the day's high, with a trading volume of 849,50K. Over the past 52 weeks, COR has traded between $308,54 to $324,88, and the current price is -1,22% away from the 52-week high.

COR Key Stats

Yesterday's Close$320,96
Market Cap$62,42B
Volume849,50K
P/E Ratio38,97
Dividend Yield (TTM)0,71%
Dividend Amount$0,60
Diluted EPS (TTM)8,36
Net Income (FY)$1,55B
Revenue (FY)$321,33B
Earnings Date2026-05-06
EPS Estimate4,83
Revenue Estimate$81,27B
Shares Outstanding194,48M
Beta (1Y)0.718
Ex-Dividend Date2026-02-13
Dividend Payment Date2026-03-02

About COR

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
SectorHealthcare
IndustryMedical - Distribution
CEORobert Mauch
HeadquartersConshohocken,PA,US
Official Websitehttps://www.cencora.com
Employees (FY)51,00K
Average Revenue (1Y)$6,30M
Net Income per Employee$30,47K

Cencora Inc. (COR) FAQ

What's the stock price of Cencora Inc. (COR) today?

x
Cencora Inc. (COR) is currently trading at $320,89, with a 24h change of -0,02%. The 52-week trading range is $308,54–$324,88.

What are the 52-week high and low prices for Cencora Inc. (COR)?

x

What is the price-to-earnings (P/E) ratio of Cencora Inc. (COR)? What does it indicate?

x

What is the market cap of Cencora Inc. (COR)?

x

What is the most recent quarterly earnings per share (EPS) for Cencora Inc. (COR)?

x

Should you buy or sell Cencora Inc. (COR) now?

x

What factors can affect the stock price of Cencora Inc. (COR)?

x

How to buy Cencora Inc. (COR) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

Cencora Inc. (COR) Latest News

2025-06-10 09:36

Union完成可信设置,为实现去信任跨链DeFi铺路

Gate News bot 消息,Union 创下零知识基础设施的新纪录,其 Groth16 可信设置仪式已结束,共收到 4,664 份已验证贡献,超越了 Manta Network 于 2023 年创下的纪录,另有 4,590 份贡献仍在等待中。这为使用简洁的有效性证明来验证共识和跨链消息奠定了加密基础。 可信设置仪式对于零知识证明系统至关重要。Union 使其能够充当“区块链中的区块链”,在以太坊、Cosmos、Arbitrum、Babylon 甚至比特币的 L2 层之间提供可验证的消息传递和资产转移,而无需依赖任何中心化参与者。 Union 首席技术官 Cor Pruijs表示:“Union 的 Groth16 可信设置仪式拥有史上最大规模,这意味着它拥有最小的诚实假设。” “诚实假设”是指为了确保最终加密参数的安全,参与者必须诚实行事(即不泄露或重复使用其私有随机数)的最小数量。 消息来源:Blockworks

2025-06-04 05:18

招银国际:升众安在线目标价至20.4港元 稳定币前景带来估值重估空间

Gate News bot 消息,招银国际发表研究报告指,随著香港稳定币条例将于今年生效,相信首批参与金管局稳定币发行商沙盒的公司将成为香港虚拟资产资金流动的主要受惠者,并为关联公司带来业绩上升的机会。 在保险方面,该行认为强劲的医疗和汽车保费带来的收入增长,以及CoR的改善将巩固利润结构。该行上调众安在线2025至27财年的每股盈测,分别至0.69、0.79及0.93元人民币,目标价由16港元调升至20.4港元,维持“买入”评级。 消息来源:金十

Hot Posts su Cencora Inc. (COR)

CryptoMotivator

CryptoMotivator

11 ore fa
Você já parou pra pensar em como ler um gráfico de velas? Pois é, essa é uma das habilidades mais importantes que um trader pode desenvolver. As velas são basicamente a forma mais intuitiva de visualizar movimento de preços, e padrões formados por elas conseguem revelar muito sobre o que está acontecendo no mercado. Uma vela nada mais é que um resumo do dia de negociação. Ela tem um corpo (que vai do preço de abertura ao fechamento) e dois pavios que mostram as máximas e mínimas. Cor verde significa alta, cor vermelha significa baixa. Simples assim. Mas quando você começa a observar como essas velas se comportam em sequência, aí surgem os padrões que realmente importam. O legal é que existem padrões muito previsíveis. Alguns indicam que o preço vai virar (reversão), outros mostram que a tendência atual vai continuar. Como trader, você quer aprender a identificar esses sinais antes da maioria. Vamos aos padrões de alta primeiro. O Martelo é clássico - aparece no fundo de uma queda e mostra que os compradores conseguiram empurrar o preço pra cima mesmo com pressão de venda. Tem também a Absorção de Alta, onde uma vela vermelha pequena é completamente engolida por uma vela verde maior. Muito sinal de força dos compradores. A Estrela da Manhã é meu favorito - três velas que formam um padrão bem característico e sinaliza esperança após uma queda. E os Três Soldados Brancos? Três velas verdes consecutivas subindo cada vez mais alto - isso é um sinal de alta bem forte. No lado oposto, temos os padrões de baixa. O Homem Enforcado é basicamente o inverso do Martelo - aparece no topo e avisa que os vendedores estão ganhando força. A Estrela Cadente funciona parecido. Depois tem a Absorção de Baixa, onde uma vela vermelha grande engole uma vela verde pequena, e os Três Corvos Negros - três velas vermelhas seguidas caindo cada vez mais. Esses padrões de baixa são importantes pra fechar posições longas no momento certo. Agora, tem uns padrões que não indicam mudança de direção, mas sim consolidação. O Doji é o mais famoso - acontece quando abertura e fechamento ficam quase no mesmo lugar, formando uma cruz. Isso mostra indecisão no mercado, ninguém ganhando. Padrões de continuação como o Método dos Três Ascendentes mostram que mesmo com alguma pressão contrária, a tendência principal vai seguir. O mais importante é praticar. Abra uma conta demo e comece a observar esses padrões em tempo real. Um trader experiente consegue identificar essas formações rapidinho e tomar decisões. Mas lembre-se: velas são poderosas, mas nunca use apenas um padrão isolado. Combine com outras análises técnicas pra confirmar o que você está vendo. O mercado é complexo, e quanto mais ferramentas você dominar, melhor suas chances de sucesso.
1
0
0
0
SleepTrader

SleepTrader

14 ore fa
* * * **Discover top fintech news and events!** **Subscribe to FinTech Weekly's newsletter** **Read by executives at JP Morgan, Coinbase, Blackrock, Klarna and more** * * * **CoreWeave to Invest Up to $23 Billion to Expand AI Infrastructure** --------------------------------------------------------------------- CoreWeave, a U.S.-based AI cloud hosting company, has announced plans to invest between $20 billion and $23 billion this year in expanding its AI infrastructure and data center capacity. **This significant capital infusion aims to cater to the growing demand for AI processing power**, particularly from clients like Microsoft, as reported by Reuters. The company’s CEO, Mike Intrator, discussed the ambitious investment strategy, noting that its unique approach to structuring debt and capital spending may take time for the market to fully understand.  **READ MORE: CoreWeave IPO Opens Below Expectations, Ends First Day Without Gains** **Massive Capital Expenditure Plans** ------------------------------------- CoreWeave’s capital expenditure for the second quarter of 2025 is projected to range between $3 billion and $3.5 billion. This is considerably higher than the company’s revenue expectations for the period, which are between $1.06 billion and $1.1 billion. **Despite these large capital expenditures, the company aims to maintain profitability while scaling its operations** to meet the demands of its rapidly expanding client base. Intrator also emphasized the company’s strategy to diversify its supply chains in light of the ongoing U.S.-China trade tensions, which could impact costs and logistics. **Impressive Revenue Growth and Challenges** -------------------------------------------- In its latest quarterly report, CoreWeave revealed a remarkable 420% increase in revenue for the quarter ending March 31, 2025. The company’s revenue surged to $188.7 million from $45.5 million in the same period last year. **Despite this impressive growth, CoreWeave also reported a widened net loss of $314.6 million**, up from $129.2 million the previous year. A significant portion of this loss was attributed to $177 million in stock-based compensation tied to the company's recent initial public offering (IPO). Despite the net loss, the company’s strong revenue performance highlights its growing presence in the AI infrastructure market. **CoreWeave’s Backlog and Key Deals** ------------------------------------- As of March 31, 2025, CoreWeave reported a revenue backlog of $25.9 billion, indicating strong future demand for its AI infrastructure services. **A major contributor to this backlog is a five-year agreement with OpenAI**, one of the leading AI research companies. The $11.9 billion deal will provide OpenAI with the necessary AI infrastructure, reinforcing CoreWeave’s position as a key player in the AI cloud hosting space. Additionally, as part of the agreement, OpenAI has agreed to invest $350 million in CoreWeave through the purchase of company stock, further strengthening the partnership between the two entities. **Looking Ahead: A Strong Position in the AI Market** ----------------------------------------------------- CoreWeave’s ambitious $23 billion investment plan underscores the company’s commitment to positioning itself as a leading provider of AI infrastructure services. By significantly expanding its data center capacity and bolstering its offerings to clients like Microsoft and OpenAI, CoreWeave aims to meet the increasing demand for AI-powered cloud hosting solutions. However, as the company navigates its growing pains, including high capital expenditure and ongoing losses linked to its IPO, CoreWeave will need to carefully balance its growth strategy with profitability. The market’s response to the company’s future plans, including the impact of its supply chain diversification efforts, will be key in determining its long-term success in the competitive AI infrastructure market.
0
0
0
0
K-LinePoet

K-LinePoet

17 ore fa
2026年3月5日,保健护理产品经销商公司Cencora(COR)成交额为6.06亿美元,在当日美股中排第243名,成交额较昨日增加109.07%,当日成交量为169.57万。 Cencora(COR)于2026年3月5日跌2.42%,报359.28美元,该股过去5个交易日跌2.01%,整个3月跌3.46%,年初至今涨6.37%,过去52周涨42.84%。 *如果公司上市时间少于52周,则52周涨跌幅为上市至今涨跌幅(同样适用于上市时间少于1个月或少于5个交易日的情况) | Cencora(COR) | 成交额/美元 | 成交额较昨日变化 | 成交量 | | --- | --- | --- | --- | | 2026年3月5日 | 6.06亿 | 109.07% | 169.57万 | | 2026年3月4日 | 2.90亿 | -33.73% | 78.62万 | | 2026年3月3日 | 4.37亿 | 19.46% | 119.08万 | | 2026年3月2日 | 3.66亿 | -29.97% | 98.38万 | | 2026年2月27日 | 5.23亿 | 19.98% | 140.68万 | Cencora于2026年2月4日发布2026财年一季报,2025年10月1日至2025年12月31日的收入为859.32亿美元,同比增长5.45%,净利润为5.66亿美元,同比增长14.67%。 Cencora, Inc.是全球最大的药品采购和分销服务公司之一,帮助医疗保健供应商以及制药和生物技术制造商改善患者获得产品加强患者护理的机会。该公司提供创新计划和服务,旨在提高药品供应链在人类和动物健康方面的效力和效率。更具体地说,该公司向位于美国和部分全球市场的各种医疗保健提供商提供全面的品牌、专业品牌和非专利药品、非处方医疗产品、家庭医疗用品和设备以及相关服务,包括急性病医院和卫生系统、独立和连锁零售药店、邮购药房、诊所、长期护理和替代地点药房、医师执业、医疗和透析诊所、兽医和其他客户。此外,公司还为医疗保健提供商和制药制造商提供各种相关服务,包括数据分析、结果研究、报销和药物咨询服务、利基优质物流服务、库存管理、药房自动化、药房管理和包装解决方案。
0
0
0
0